Ligand Pharmaceuticals (LGND) Net Income (QoQ) (2010 - 2026)
Ligand Pharmaceuticals (LGND) Net Income (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | Ligand Pharmaceuticals | 6.01 Bn | 5.24 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129.80% |
| Dec 31, 2025 | -61.81% |
| Sep 30, 2025 | 2,319.50% |
| Jun 30, 2025 | 111.42% |
| Mar 31, 2025 | -36.55% |
| Mar 31, 2023 | 43.58% |
| Dec 31, 2022 | 68.07% |
| Sep 30, 2022 | 31.52% |
| Jun 30, 2022 | -449.43% |
| Mar 31, 2022 | -10.48% |
| Dec 31, 2021 | 66.39% |
| Sep 30, 2021 | -15.71% |
| Jun 30, 2021 | -22.68% |
| Mar 31, 2021 | -126.49% |
| Dec 31, 2020 | 362.51% |
| Sep 30, 2020 | -130.34% |
| Jun 30, 2020 | 191.53% |
| Mar 31, 2020 | -227.64% |
| Dec 31, 2019 | 51.71% |
| Sep 30, 2019 | -5.77% |